Skip to main content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
BMC Cardiovasc Disord. 2024; 24: 290.
Published online 2024 Jun 1. doi: 10.1186/s12872-024-03890-3
PMCID: PMC11143634
PMID: 38822250

Changes in patient profiles in the cardiology department of the University Hospital Gabriel Touré (UH-GT) : results of two cross-sectional studies of 2010 and 2022

Associated Data

Data Availability Statement

Abstract

Background

Little is known about patient profile changes in medical facilities in our country, leading to this study to describe and compare patient profiles in 2010 and 2022.

Patients and methods

This was a cross-sectional study with new outpatients aged 15 years and more seen in the cardiology department of the UH-GT. Measurements included height, weight and body mass index (BMI). Systolic blood pressure (SBP) and diastolic blood pressure (DBP) were recorded. Quantitative data are presented as the mean with standard deviation, and categorical one as proportions. Statistical tests were the t test to compare means and chi-test for categorical variables. The level of significance was set to 0.05.

Results

The sample consisted of 515 new patients (199 in 2010 and 316 in 2022) with 59.1% female in 2010 and 60.1% in 2022 (p = 0.821). We noticed an increase in hypertension (59.1–71.8%, p = 0.003) and a decrease in tobacco smoking (from 13 to 05.4%, p = 0.002) and stroke (from 05.8 to 02.2%, p = 0.033). Height increased significantly from 1.59 m to 1.66 m, p = 0.002. SBP and DBP showed significant decreases in their means from 155.43 to 144.97 mmHg, p = < 0.001 for SBP and from 95.53 to 89.02 mmHg, p = < 0.001 for DBP.

Conclusions

Cardiovascular risk factors showed different trends with decreasing tobacco smoking, similar to systolic and diastolic blood pressure, albeit with an increase in hypertension prevalence. Other CVrf values increased. Awareness campaigns must be reinforced and maintained to obtain their decrease.

Keywords: Cardiovascular risk factor, Trend, Cardiology, Mali, University hospital, Outpatient

Background

Cardiology is one of the solicited departments in medical facilities due to different factors. Cardiovascular diseases (CVDs) are the leading cause of death according to the WHO [1]. Another fact is that the burden of CVD with prevalent cases nearly doubled from 271 in 1990 to 523 million in 2019 [2] and that over 70% of CVD cases and deaths in the overall cohort were attributed to modifiable risk factors [3]. According to Hinton, CVD represents one-fifth of adult patients [4], and continent-wide, the median age-standardized incidence was lower in middle-income countries than in high-income countries (1039 vs. 1224) (IQR 11,061,356)] for both females and males [5].

Low- and middle-income countries (LMICs) are most affected, with more than 80% of these cases [6, 7] and more than doubling in our neighboring countries [8].

However, little is known about patient profile changes in medical facilities in our country, leading to this study, which aims to describe and compare patient profiles over a 12-year time interval (2010 and 2022).

Patients and methods

Study design

The study was designed as a cross-sectional study including all new outpatients aged 15 years and more seen in the cardiology department of the UH-GT.

We replicated a previous study performed from December 1, 2009, to January 31, 2010, in the cardiology department of the University Hospital Gabriel Touré in Bamako (UH-GT). The actual study was conducted from July 04 to December 02, 2022.

Setting

The UH-GT is an university teaching hospital with a cardiology department in Bamako, Mali. In the setting are relevant laboratory tests available as well as imaging modalities such as transthoracic echocardiography, electrocardiography and long time blood pressure and heart rhythm recording systems.

Participants

Include were all participants aged 15 years and more, regardless of sex and seen in the outpatient unit in the study period.

Informed consent was obtained freely and voluntarily after being explanation of the study goal, collected data, the confidential treatment of their data and more importantly that the participation is not mandatory. We didn’t need to exclude patients.

Variables and data Collection

Study variables involved sociodemographics (age, gender, residence and education level) obtained through direct interrogation of patients. Education level was evaluated as school attendance in years and presented as categories with none, primary, secondary and university for 0, 1–9, 10–12 and more than 12 years of school attendance, respectively.

Measurements including height in m and weight in kg were recorded as quantitative variables. Body mass index (BMI) in kg/m2 was calculated from height and weight as weight/height2. BMI was then classified as normal, overweight and obese for 18,5- less than 25, ≥ 25 and < 30 and ≥ 30, respectively.

Systolic blood pressure (SBP) and diastolic blood pressure (DBP) were recorded as quantitative variables in mmHg after being measured 3 consecutive times using an automatic sphygmomanometer (OMRON) after a 5-minute rest.

Data were collected through a validated survey formular and added to the same Microsoft Access database from the 2010 study.

Analysis was performed using IBM SPSS software. Quantitative data are presented as the mean with standard deviation, and categorical data are presented as proportions. Statistical tests were the t test to compare means and chi-test for categorical variables. The level of significance was set to 0.05.

Results

The sample consisted of 515 new patients (199 in 2010 and 316 in 2022).

The female sex was most represented (59.1%) in 2010 and 60.1% in 2022, with a p value of 0.821. There were more patients with increasing age, but the differences were not significant. The distribution of school attendance showed no significant difference (Table 1).

Table 1

distribution of the sociodemographic characteristics of 515 patients according to the year of study

Variables2010
N(%)
2022
N(%)
p
SexMale085 (40.9)126 (39.9)0.821
Female123 (59.1)190 (60.1)
Age group (years)< 30033 (15.9)038 (12.0)0.392
40–44037 (17.8)072 (22.8)
45–59062 (29.8)089 (28.2)
≥ 60076 (36.5)117 (37.0)
School attendingNone114 (58.7)161 (52.3)0.516
Primary043 (21.9)082 (26.6)
Secondary026 (13.3)042 (13.6)
University012 (06.1)023 (07.5)

The distribution of cardiovascular risk factors (CVrf) showed an increase in hypertension (59.1–71.8%, p = 0.003) and a decrease in tobacco smoking (from 13 to 05.4%, p = 0.002). A similar decrease in stroke was found (from 05.8 to 02.2%, p = 0.033). Diabetes, alcohol consumption and obesity did not show a significant difference (Table 2).

Table 2

Distribution of cardiovascular risk factors among 515 newly diagnosed hypertensive patients according to year of study

Variables20102022Np
Hypertension123 (59.1)227 (71.8)3500.003
Diabetes013 (06.2)026 (08.2)0390.399
Tobacco smoking027 (13.0)017 (05.4)0440.002
Alcohol consumption204 (01.9)312 (01.3)0080.548
Stroke012 (05.8)007 (02.2)0190.033
Body mass index (kg/m2)< 25106 (57.0)164 (52.4)2700.423
25–29044 (23.7)073 (23.3)117
≥ 30036 (19.4)076 (24.3)112

In terms of family history, only hypertension and diabetes were found to be different. A family history of hypertension decreased from 51.9 to 17.4%, p < 0.001, and diabetes decreased from 10.6 to 04.4%, p = 0.006 (Table 3).

Table 3

distribution of family cardiovascular risk factors and death according to study year

Variables20102022p
Hypertension108 (51.9)055 (17.4)< 0.001
Diabetes022 (10.6)014 (04.4)0.006
Stroke005 (02.4)002 (00.6)0.084
Death due toHypertension004 (01.9)004 (01.3)0.548
Diabetes001 (00.5)001 (00.3)0.765

Among anthropometric variables, only mean height increased significantly from 1.59 to 1.66%, p = 0.002. Age, weight and body mass index (BMI) showed increases that were not significant (Table 4).

Table 4

distribution of mean anthropometric variables according to study year for 199 2010 patients 2010 and 316 2022 patients

Variablest(df)20102022Diff*p
MeanSDMeanSD
Age (years)-0.190(522)50.1218.63550.4116.281-0.2930.849
Weight (kg)-0.408(502)70.7717.45771.4317.929-0.6680.683
Height (m)-3.113(512)1.590.3931.660.094-0.0720.002
BMI+ (kg/m2)-1.746(501)24.995.98325.9966.430-1.0090.081

*Difference+Body mass index

Systolic blood pressure (SBP) and diastolic blood pressure (DBP) showed significant decreases in their means. Therefore, SBP decreased from 155.43 to 144.97 mmHg, p = < 0.001, and DBP decreased from 95.53 to 89.02 mmHg, p = < 0.001, giving mean differences of 10.459 and 6.509, respectively. The mean difference in heart rate was not significant (p = 0.144) (Table 5).

Table 5

distribution of mean pressure values according to study year for 199 2010 patients 2010 and 316 2022 patients

Variablest(df)20102022Diff*p
MeanSDMeanSD
SBP+ (mmHg)3,841(513)155.4333,070144.9728,05310.459< 0.001
DBP++ (mmHg)3,975(513)95.5318.189189.0218.0306.509< 0.001
HR+++ (/min)1.465(508)86.9317.20284.6616.8842.2720.144

*Difference+systolic blood pressure ++diastolic blood pressure +++ heart rate

Discussion

There is a lack of trend studies in our environment, and this study is the first in its kind in our department.

The main findings resulting from our study are as follows:

  • Patients attending the facility.

    The patients of the two independent samples composing this study were similar in terms of gender, age and education level, as shown in Table I, meaning that no structural change occurred.

    The prevalence of females is a common finding in most studies [811], but for some authors, it warrants periodic re-examination [12]. Many factors, including psychosocial problems or distress and easier divulgation of personal information [13], have been underscored. This higher rate of female attendance and a female excess of physical symptoms has been found to be independent of the number and nature of symptoms measured, the time frame involved, and the response format and scoring method used [14].

  • Distribution of cardiovascular risk factors.

    We found a significant increase in hypertension in this study. There is no clear trend in the distribution of CVrf worldwide. Most authors found an increase in hypertension and dyslipidemia. So found Jardim et al. an increase of hypertension prevalence from 6.0 to 16.7% with p = 0.024 and dyslipidemia from 4.0 to 19.14% with p = 0.002) [15]. This increase was similar to Fores data with 15.4% [16] and more pronounced particularly for sub-Saharan Africa about 20% [17] [1517]. There is even an increase in the mean number of CVrf in men and women [18]. Data from the Czech Republic found a decrease in total cholesterol and the mean population blood pressure [19], whereas Castel-Faced found no significant changes in CVrf in a cluster analysis [20].

    Diabetes as a major CVrf shows a decrease in high-income countries and an increase in low- and middle-income countries [21, 22]. Recent studies show a shifting risk factor profile toward a younger population with lower rates of established CVD from the onset of the COVID-19 pandemic [23].

    Tobacco smoking, as another major CVrf, decreased in this study, consistent with most studies [19], but data from Switzerland pointed out a striking increase in tobacco smoking in women [18]. The different regular awareness campaigns from the state and stakeholders such as the Malian cardiac society, among others, are possibly playing a role in this decrease.

  • Anthropometric variables.

    BMI in this study shows an increase that was not significant and not consistent with literature data showing an increase in BMI events for children and adolescents [24], and with continuing trends, by 2025, global obesity prevalence will reach 18% in men and surpass 21% in women; severe obesity will surpass 6% in men and 9% in women [25, 26].

  • Blood pressure on admission.

    We found a decrease in the levels of SBP and DBP on admission, although hypertension increased. This is in opposition to studies with rising SBP and DBP, as reported by Churilova [27], and the relationship of mean blood pressure and the prevalence of hypertension [28]. An explanation could be the role of traditional medication that is not always confessed and therefore not recorded during patient questioning.

Limitations

Despite its strength through providing data on changes in patient profiles in the cardiology department in a low-income country, this study has some limitations. It was conducted without a funding not allowing to include more patients and extend to several months. The lack of labor data essentially due to their cost for patients (most of them don’t benefit from a medical insurance) is another limitation of this study.

Conclusion

Cardiovascular risk factors showed different trends with decreasing tobacco smoking, similar to systolic and diastolic blood pressure, albeit with an increase in hypertension prevalence. Other CVrf values increased. Awareness campaigns must be reinforced and maintained to obtain a decrease in all CVrf.

Acknowledgements

Not applicable.

Abbreviations

BMIbody mass index
CVDcardiovascular diseases
CVrfcardiovascular risk factors
DBPdiastolic blood pressure
HRhealth rate
IBM SPSSInternational Business Machine Statistical Software Package for Social Sciences
LMIClow- and middle-income countries
SBPsystolic blood pressure
UH-GTUniversity Hospital Gabriel Touré
WHOWorld Health Organization

Author contributions

BA HO designed the study. Poudiougou M was responsible for data collection. BA HO, Camara Y, Sangaré I and Menta I were responsible for the statistical analysis. BA HO and Poudiougou M wrote the first draft. Camara Y, Sangare I and Menta reviewed and checked the manuscript. All authors have read and approved the final version of the manuscript.

Funding

This study did not receive any specific grants from funding agencies in the public, commercial, or nonprofit sectors.

Data availability

The data used to support the findings of this study are available from the corresponding author upon request.

Declarations

Competing interests

The authors declare no competing interests.

Ethical approval and consent to participate

The study was approved as part of the University Hospital’s research activities by the institutional board.

Informed consent

was obtained from all subjects and also their legal guardian(s) for younger participants.

Consent for publication

Not applicable.

Footnotes

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

1. Cardiovascular diseases (CVDs). [Internet]. [cited 2021 Oct 11]. https://www.who.int/fr/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds).
2. Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global Burden of Cardiovascular diseases and Risk factors, 1990–2019. J Am Coll Cardiol. 2020;76(25):2982–3021. doi: 10.1016/j.jacc.2020.11.010. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
3. Yusuf S, Joseph P, Rangarajan S, Islam S, Mente A, Hystad P, et al. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet. 2020;395(10226):795–808. doi: 10.1016/S0140-6736(19)32008-2. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
4. Hinton W, McGovern A, Coyle R, Han TS, Sharma P, Correa A, et al. Incidence and prevalence of cardiovascular disease in English primary care: a cross-sectional and follow-up study of the Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) BMJ Open. 2018;8(8):e020282. doi: 10.1136/bmjopen-2017-020282. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
5. Timmis A, Townsend N, Gale CP, Torbica A, Lettino M, Petersen SE, et al. European Society of Cardiology: Cardiovascular Disease statistics 2019. Eur Heart J. 2020;41(1):12–85. doi: 10.1093/eurheartj/ehz859. [PubMed] [CrossRef] [Google Scholar]
6. Yusuf S, Rangarajan S, Teo K, Islam S, Li W, Liu L, et al. Cardiovascular risk and events in 17 Low-, Middle-, and high-income countries. N Engl J Med. 2014;371(9):818–27. doi: 10.1056/NEJMoa1311890. [PubMed] [CrossRef] [Google Scholar]
7. Bowry ADK, Lewey J, Dugani SB, Choudhry NK. The Burden of Cardiovascular Disease in Low- and Middle-Income countries: Epidemiology and Management. Can J Cardiol. 2015;31(9):1151–9. doi: 10.1016/j.cjca.2015.06.028. [PubMed] [CrossRef] [Google Scholar]
8. Yayehd K, Damorou F, N’Da NW, Tchérou T, Tété Y, Johnson A, et al. Évolution Des admissions pour maladies cardiovasculaires en milieu cardiologique à Lomé: étude transversale de 7959 patients de Juin 2004 à Mai 2009. Rev DÉpidémiologie Santé Publique. 2012;60(3):205–11. doi: 10.1016/j.respe.2012.02.002. [PubMed] [CrossRef] [Google Scholar]
9. Keene J, Li X. Age and Gender Differences in Health Service utilization. J Public Health. 2005;27(1):74–9. doi: 10.1093/pubmed/fdh208. [PubMed] [CrossRef] [Google Scholar]
10. Gerritsen AA, Devillé WL. Gender differences in health and health care utilization in various ethnic groups in the Netherlands: a cross-sectional study. BMC Public Health. 2009;9(1):109. doi: 10.1186/1471-2458-9-109. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
11. Bertakis KD, Azari R, Helms LJ, Callahan EJ, Robbins JA. Gender differences in the utilization of health care services. J Fam Pract. 2000;49(2):147–52. [PubMed] [Google Scholar]
12. Macintyre S, Hunt K, Sweeting H. Gender differences in health: are things truly as simple as they seem? Soc Sci Med. 1996;42(4):617–24. doi: 10.1016/0277-9536(95)00335-5. [PubMed] [CrossRef] [Google Scholar]
13. Corney RH. Sex differences in general practice attendance and help seeking for minor illness. J Psychosom Res. 1990;34(5):525–34. doi: 10.1016/0022-3999(90)90027-2. [PubMed] [CrossRef] [Google Scholar]
14. Van Wijk CMTG, Kolk AM. Sex differences in physical symptoms: the contribution of symptom perception theory. Soc Sci Med. 1997;45(2):231–46. doi: 10.1016/S0277-9536(96)00340-1. [PubMed] [CrossRef] [Google Scholar]
15. Jardim T, Jardim P, Araujo W, Salgado C, Siqueira L, Sousa A. CARDIOVASCULAR RISK FACTORS EVOLUTION IN A GROUP OF MEDICAL PROFESSIONALS – 15 YEARS FOLLOW-UP: PP.19.241. J Hypertens. 2010;28:e321. doi: 10.1097/01.hjh.0000379167.88864.ed. [CrossRef] [Google Scholar]
16. Forés R, Alzamora MT, Pera G, Valverde M, Angla M, Baena-Díez JM, et al. Evolution and degree of control of cardiovascular risk factors after 5 years of follow-up and their relationship with the incidence of peripheral arterial disease: ARTPER cohort. Med Clínica Engl Ed. 2017;148(3):107–13. [PubMed] [Google Scholar]
17. Zhou B, Bentham J, Di Cesare M, Bixby H, Danaei G, Cowan MJ, et al. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet. 2017;389(10064):37–55. doi: 10.1016/S0140-6736(16)31919-5. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
18. Cimci M, Witassek F, Radovanovic D, Rickli H, Pedrazzini GB, Erne P, et al. Temporal trends in cardiovascular risk factors’ prevalence in patients with myocardial infarction. Eur J Clin Invest. 2021;51(4):e13466. doi: 10.1111/eci.13466. [PubMed] [CrossRef] [Google Scholar]
19. Cífková R, Bruthans J, Wohlfahrt P, Krajčoviechová A, Šulc P, Jozífová M, et al. 30-year trends in major cardiovascular risk factors in the Czech population, Czech MONICA and Czech post-MONICA, 1985–2016/17. Shimosawa T, editor. PLoS ONE. 2020;15(5):e0232845. doi: 10.1371/journal.pone.0232845. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
20. Castel-Feced S, Maldonado L, Aguilar-Palacio I, Malo S, Moreno-Franco B, Mur-Vispe E, et al. Evolution of Cardiovascular Risk factors in a worker cohort: a cluster analysis. Int J Environ Res Public Health. 2021;18(11):5610. doi: 10.3390/ijerph18115610. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
21. Zhou B, Lu Y, Hajifathalian K, Bentham J, Di Cesare M, Danaei G, et al. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants. Lancet. 2016;387(10027):1513–30. doi: 10.1016/S0140-6736(16)00618-8. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
22. Feng L, Lam A, Carmody D, Lim CW, Tan G, Goh SY, et al. Trends in cardiovascular risk factors and treatment goals in patients with diabetes in Singapore-analysis of the SingHealth Diabetes Registry. PLoS ONE. 2021;16(11):e0259157. doi: 10.1371/journal.pone.0259157. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
23. Hall EJ, Ayers CR, Kolkailah AA, Rutan C, Walchok J, Williams JH, et al. Longitudinal trends in Cardiovascular Risk factor profiles and complications among patients hospitalized for COVID-19 infection: results from the American Heart Association COVID-19 Cardiovascular Disease Registry. Circ Cardiovasc Qual Outcomes. 2023;16(5):e009652. doi: 10.1161/CIRCOUTCOMES.122.009652. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
24. NCD Risk Factor Collaboration (NCD-RisC) Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet Lond Engl. 2017;390(10113):2627–42. doi: 10.1016/S0140-6736(17)32129-3. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
25. Trends in adult Body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet. 2016;387(10026):1377–96. doi: 10.1016/S0140-6736(16)30054-X. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
26. Patterns and trends in excess weight among adults in England. - UK Health Security Agency [Internet]. [cited 2022 Feb 7]. https://ukhsa.blog.gov.uk/2021/03/04/patterns-and-trends-in-excess-weight-among-adults-in-england/.
27. Churilova E, Shkolnikov VM, Shalnova SA, Kudryavtsev AV, Malyutina S, Nilssen O, et al. Long-term trends in blood pressure and hypertension in Russia: an analysis of data from 14 health surveys conducted in 1975–2017. BMC Public Health. 2021;21(1):2226. doi: 10.1186/s12889-021-12320-4. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
28. NCD Risk Factor Collaboration (NCD-RisC) Contributions of mean and shape of blood pressure distribution to worldwide trends and variations in raised blood pressure: a pooled analysis of 1018 population-based measurement studies with 88.6 million participants. Int J Epidemiol. 2018;47(3):872–i883. doi: 10.1093/ije/dyy016. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

Articles from BMC Cardiovascular Disorders are provided here courtesy of BMC

-